FDA Releases Final Guidance on Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements | Sheppard Mullin Richter & Hampton LLP
On June 27, 2023, the Food and Drug Administration (FDA) issued its final guidance for the presentation of “Quantitative Efficacy and Risk Information” in direct-to-consumer (DTC)...
Sheppard Mullin Richter Hampton Prescription Drug Promotion On Television Study Of Oncology Indications In Television Advertising See Us Food Drug Administration See Untitled Letter To Xeris Pharmaceuticals Publication Office Of Prescription Drug Promotion
Source: jdsupra.com